Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
Related Articles
Cited By...
- Application of balloon-expandable stent angioplasty with dIstal support of the stent-retriever (BASIS-Stent) technique for acute intracranial artery atherosclerosis-related occlusion
- Comparison of drug-coated balloon with bare-metal stent in patients with symptomatic intracranial atherosclerotic stenosis: the AcoArt sICAS randomized clinical trial
- Evaluation of safety and efficacy of intracranial self-expanding drug-eluting stents for symptomatic intracranial atherosclerotic stenosis: a prospective, multicentre, randomised controlled, superiority clinical trial protocol
- Calcification is a risk factor for intracranial in-stent restenosis: an optical coherence tomography study
- Balloon-mounted stenting for ICAS in a multicenter registry study in China: a comparison with the WEAVE/WOVEN trial
- Stenting for symptomatic intracranial arterial stenosis in China: 1-year outcome of a multicentre registry study
- Multicenter Prospective Trial of Stent Placement in Patients with Symptomatic High-Grade Intracranial Stenosis
- Thirty-Day Outcome of a Multicenter Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China
- Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRIS
- Off-Label Use of Drugs and Devices in the Neuroendovascular Suite
- Standard of practice: endovascular treatment of intracranial atherosclerosis
- Detection of Intracranial In-Stent Restenosis Using Quantitative Magnetic Resonance Angiography
- In-Hospital Complication Rates After Stent Treatment of 388 Symptomatic Intracranial Stenoses: Results From the INTRASTENT Multicentric Registry
- Treatment of Atherosclerotic Intracranial Arterial Stenosis
- A Systematic Review on Outcome After Stenting for Intracranial Atherosclerosis
- Comparison of Primary Angioplasty With Stent Placement for Treating Symptomatic Intracranial Atherosclerotic Diseases: A Multicenter Study